日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of Telitacicept in IgA nephropathy and its impact on urinary Gd-IgA1: insights from a real-world study

Telitacicept治疗IgA肾病的疗效和安全性及其对尿Gd-IgA1的影响：一项真实世界研究的启示

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1694197
Li, Hongfen; Li, Wenying; Wang, Fanghao; Xing, Yue; Wu, Zhanfei; Jia, Junya; Liu, Youxia; Yan, Tiekun
IgA
发表日期：2026
文献求助 收藏

Treatment patterns, clinical outcomes, and economic burden among patients with immunoglobulin A nephropathy (IgAN) in China

中国免疫球蛋白A肾病（IgAN）患者的治疗模式、临床结果和经济负担

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-025-04709-9
Liu, Youxia; Xing, Yue; Li, Hongfen; Qi, Yan; Nunna, Sasikiran; Chen, Zhaoxin; Zhuang, Yuelin; Zhang, Yilong; Lu, Wentian; Kou, Jiaqi; Lin, Xiaoyu; Zuo, Li; Yan, Tiekun
IgA
免疫/内分泌
发表日期：2026
文献求助 收藏

Efficacy of semaglutide in IgA nephropathy with obesity: a case report

索玛鲁肽治疗肥胖型IgA肾病的疗效：病例报告

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-026-04784-6
Li, Hongfen; Jia, Junya; Wei, Li; Shang, Wenya; Liu, Youxia
IgA
肥胖
代谢
发表日期：2026
文献求助 收藏

The efficacy and safety of RNA interference for the treatment of primary hyperoxaluria: a systematic review and meta-analysis

RNA干扰治疗原发性高草酸尿症的疗效和安全性：系统评价和荟萃分析

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfae383
Yu, Huyan; Zhong, Hongfei; Liu, Youxia; Zhang, Guilian
发表日期：2025
文献求助 收藏

The neutrophil-to-monocyte ratio: a superior inflammatory marker predicting poor prognosis in IgA nephropathy

中性粒细胞与单核细胞比值：预测IgA肾病预后不良的优良炎症标志物

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-025-04475-8
Liu, Youxia; Yu, Huyan; Luo, Yi; Li, Hongfen; Wang, Fanghao; Xing, Yue; Wu, Zhanfei; Li, Wenying; Jia, Junya; Yan, Tiekun
IgA
炎症
中性粒细胞
炎症/感染
粒细胞
单核细胞
细胞生物学
发表日期：2025
文献求助 收藏

Clinical and pathological findings of IgA nephropathy following SARS-CoV-2 infection

SARS-CoV-2感染后IgA肾病的临床和病理学发现

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-023-01271-2
Li, Hongfen; Li, Zhao; Wu, Zhanfei; Wang, Fanghao; Xing, Yue; Liu, Youxia; Jia, Junya; Yan, Tiekun
炎症/感染
IgA
SARS-CoV-2
发表日期：2024
文献求助 收藏

Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta-analysis and a propensity score-matched case-control study

贝利木单抗治疗狼疮性肾炎患者的疗效和安全性：一项荟萃分析和倾向评分匹配病例对照研究

期刊:Immunity Inflammation and Disease
影响因子:2.7
doi:10.1002/iid3.954
Zhang, Kai; Qi, Tiening; Guo, Donghua; Liu, Youxia
肾炎
发表日期：2023
文献求助 收藏

The effect of fibrinoid necrosis on the clinical features and outcomes of primary IgA nephropathy

纤维素样坏死对原发性IgA肾病临床特征和预后的影响

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-023-03419-4
Chen, Hongshan; Liu, Youxia; Wei, Li; Wang, He; Zheng, Zhenfeng; Yan, Tiekun; Jia, Junya; Li, Dong
IgA
发表日期：2023
文献求助 收藏

Elevated activating Fc gamma receptors levels correlated with susceptibility and severity of IgA nephropathy

激活型Fcγ受体水平升高与IgA肾病的易感性和严重程度相关。

期刊:Therapeutic Advances in Chronic Disease
影响因子:2.8
doi:10.1177/20406223221106878
Li, Hongfen; Liu, Youxia; Yu, Huyan; Wang, Fanghao; Jia, Junya; Yan, Tiekun; Lin, Shan
IgA
信号转导
发表日期：2022
文献求助 收藏

The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study

IgA肾病中肾病综合征患者与肾病范围蛋白尿患者的差异：一项倾向评分匹配队列研究

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-022-02799-3
Li, Hongfen; Wang, Fanghao; Jia, Junya; Yan, Tiekun; Liu, Youxia; Lin, Shan
IgA
发表日期：2022
文献求助 收藏